Bed and Breakfast (B&B) Study

NCT ID: NCT02927600

Last Updated: 2017-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to determine which among high vs low Glycemic Index (GI) / Glycemic Responses (GR) interventions at breakfast or at dinner is the most effective for lowering glycemic response of the subsequent standard meal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consumption of low Glycemic Index (GI) foods has been shown to not only attenuate blood glucose response during the postprandial period immediately following a meal but to have also positive metabolic effects at the subsequent meal, known as the "second-meal effect" by reducing glucose excursion beyond actual meal. The relative importance of the timing of the glycemic load variation (e.g., breakfast or dinner) on the overall, 24h, glycemic control has not been investigated in detail.

We hypothesize that eating low GI foods in a single meal either for breakfast or for dinner would have different consequential effects on glycemic control over the following meal and thereafter during 24 hours. In order to establish the relative importance of breakfast or dinner in predicting glycemic control/response of the following meal and for a 24-hour period this study will use comprehensive methods including Continuous Glucose Monitoring Systems (CGMS) as well as measuring postprandial blood glucose and insulin.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Glycemic response Glycemic index Meal intervention Chinese population

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low GI Rice Breakfast

Intake of low GI breakfast

Group Type EXPERIMENTAL

Low GI Breakfast

Intervention Type OTHER

Intake of low GI breakfast

High GI rice Breakfast

Intake of High GI breakfast

Group Type EXPERIMENTAL

High GI Breakfast

Intervention Type OTHER

Intake of high GI breakfast

Low GI Rice Dinner

Intake of low GI dinner

Group Type EXPERIMENTAL

Low GI Dinner

Intervention Type OTHER

Intake of Low GI dinner

High GI Rice Dinner

Intake of High GI dinner

Group Type EXPERIMENTAL

High GI Dinner

Intervention Type OTHER

Intake of high GI dinner

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low GI Breakfast

Intake of low GI breakfast

Intervention Type OTHER

High GI Breakfast

Intake of high GI breakfast

Intervention Type OTHER

Low GI Dinner

Intake of Low GI dinner

Intervention Type OTHER

High GI Dinner

Intake of high GI dinner

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 50 to ≤ 70 years old years
* Chinese male and female healthy subjects having both grandparents Chinese
* Body mass index: ≥ 18.5 to ≤ 24.9kg/m2
* Waist circumference ≤90 cm for males and ≤ 85 cm for females
* Systolic blood pressure \<150 mmHg; Diastolic blood pressure \<90 mmHg
* Willing and able to sign written informed consent prior to trial entry

Exclusion Criteria

* Known Diabetes type 2, under medication
* Fasting Glycemia \> 7 mmol/L
* Any clinically relevant gastrointestinal (ulcer, malabsorption), renal (insufficiency), cardiovascular (stroke, arterial hypertension, heart disease), metabolic disease (dyslipidemia), psychiatric disorder (depression) that would affect the study in the opinion of the CNRC clinician, according to a detailed medical history and a blood sampling at screening, only if deemed necessary by CNRC clinician.
* Anemia (anamnesis)
* Subjects who had a history of major gastrointestinal surgery
* Subjects who had more than 5% weight loss from baseline weight during the past three months (more than 5% of initial weight)
* Present drug abuse or use of medications that could interfere with the treatment or energetic metabolism including corticosteroids, growth hormone, hormonal replacement therapy, anti-hypertensives like ACE inhibitor, thiazides and angiotensin receptors blockers. These conditions will be screened based on subject reporting. Participants will be asked to bring in their current medications at the time of screening, and these will be checked by the study-staff.
* Subject allergic /intolerant to any of the test foods or any of the following common food and ingredients: eggs, fish, milk, peanuts, and tree nuts, shellfish, soya, wheat, gluten, cereal, fruits, dairy products, meat, vegetable, sugar and sweetener, natural food colourings or flavourings etc.
* Subject on special diets especially vegetarian, high protein or weight loss program.
* Current smokers (i.e. people having smoked in the month preceding the enrolment)
* Subjects having a high alcohol consumption (more than 2 drinks/day)
* Subjects who are not willing and not able to comply with scheduled visits and the requirements of the study procedures in the opinion of the investigators.
* Currently participating or having participated in another clinical trial within 4 weeks prior to trial start.
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Singapore Institute of Food and Biotechnology Innovation

OTHER_GOV

Sponsor Role collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christiani Jeyakumar Henry, Prof

Role: PRINCIPAL_INVESTIGATOR

Centre for Translational Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Nutrition Research Center

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

References

Explore related publications, articles, or registry entries linked to this study.

Haldar S, Egli L, De Castro CA, Tay SL, Koh MXN, Darimont C, Mace K, Henry CJ. High or low glycemic index (GI) meals at dinner results in greater postprandial glycemia compared with breakfast: a randomized controlled trial. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001099. doi: 10.1136/bmjdrc-2019-001099.

Reference Type DERIVED
PMID: 32327444 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15.18.NRC

Identifier Type: -

Identifier Source: org_study_id